Empowering genomics with proteomics

Have a seat at the table

Olink will be at the Ottawa Hospital Research Institute on April 6, 2023. Join us for coffee and pastries as well as a seminar on our novel PEA technology. We will discuss Olink’s proteomics platform and present use cases for actionable biomarker discovery underscoring the role of precision proteomics as a tool to improve health outcomes for patients with rare diseases and cancer. Register here to learn more about how proteomics can empower your research. Seats are limited – register today!

Location: Ottawa Hospital Research Institute
Sprott Centre for Stem Cell Research
5th Floor, Room G-CCW-5225
501 Smyth Road
Ottawa, ON K1H 8L6

Date: Thursday, April 6, 2023

Time: 10:00 – 11:30 AM

Agenda:

10:00 – 10:05 AM Introductions
10:05 – 10:50 AM Introduction to Olink Proteomics and Technical Overview
Case studies: Rare diseases, Immunotherapy, Cell therapy, Oncolytic viruses
10:50 – 11:00 AM Q&A
11:00 – 11:30 AM Meet the Olink team – Coffee and networking

Speaker

Michael Förster

Title: Scientific Director of Oncology and Rare Disease

Michael Förster joined Olink’s Scientific Affairs team as Director Oncology and Rare Disease. He completed his PhD on autoimmune disease genetics at Karolinska Institute and moved to McGill University for a postdoc investigating the link between primary immunodeficiency, hematopoiesis and the development of hematological malignancies.